Becton Dickinson & Co. closed 3.20% below its 52-week high of $248.42, which the company achieved on March 28th.

Abhijeet Bhardwaj's commitment to technical excellence and innovation continues to drive successful outcomes in large-scale ...

Argus Research analyst David Toung maintained a Buy rating on Johnson & Johnson (JNJ – Research Report) yesterday. The company’s shares ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of ...

BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...

Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI ...

Global Patient Safety and Risk Management Software Market Growth is Driven by Increasing Patient Safety Demands, Regulatory Compliance, and AI-Powered InnovationsPune, Jan. 24, 2025 (GLOBE NEWSWIRE) - ...

Kauvery Cancer Institute offers advanced cancer care with robotic surgery, early detection campaigns, and holistic support, ...

The phage therapy market is experiencing significant growth due to the increasing prevalence of antibiotic-resistant infections and the growing interest in alternative treatments. Advances in ...